BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12270937)

  • 1. Role of TRAF3 and -6 in the activation of the NF-kappa B and JNK pathways by X-linked ectodermal dysplasia receptor.
    Sinha SK; Zachariah S; Quiñones HI; Shindo M; Chaudhary PM
    J Biol Chem; 2002 Nov; 277(47):44953-61. PubMed ID: 12270937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XEDAR activates the non-canonical NF-κB pathway.
    Verhelst K; Gardam S; Borghi A; Kreike M; Carpentier I; Beyaert R
    Biochem Biophys Res Commun; 2015 Sep; 465(2):275-80. PubMed ID: 26260321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ectodermal dysplasia receptor activates the nuclear factor-kappaB, JNK, and cell death pathways and binds to ectodysplasin A.
    Kumar A; Eby MT; Sinha S; Jasmin A; Chaudhary PM
    J Biol Chem; 2001 Jan; 276(4):2668-77. PubMed ID: 11035039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ectodermal dysplasia receptor represses the Lef-1/beta-catenin-dependent transcription independent of NF-kappaB activation.
    Shindo M; Chaudhary PM
    Biochem Biophys Res Commun; 2004 Feb; 315(1):73-8. PubMed ID: 15013427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myodegeneration in EDA-A2 transgenic mice is prevented by XEDAR deficiency.
    Newton K; French DM; Yan M; Frantz GD; Dixit VM
    Mol Cell Biol; 2004 Feb; 24(4):1608-13. PubMed ID: 14749376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis by X-linked ectodermal dysplasia receptor via a caspase 8-dependent mechanism.
    Sinha SK; Chaudhary PM
    J Biol Chem; 2004 Oct; 279(40):41873-81. PubMed ID: 15280356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
    Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
    J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors.
    Yan M; Wang LC; Hymowitz SG; Schilbach S; Lee J; Goddard A; de Vos AM; Gao WQ; Dixit VM
    Science; 2000 Oct; 290(5491):523-7. PubMed ID: 11039935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edar signaling in the control of hair follicle development.
    Botchkarev VA; Fessing MY
    J Investig Dermatol Symp Proc; 2005 Dec; 10(3):247-51. PubMed ID: 16382675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling and subcellular localization of the TNF receptor Edar.
    Koppinen P; Pispa J; Laurikkala J; Thesleff I; Mikkola ML
    Exp Cell Res; 2001 Oct; 269(2):180-92. PubMed ID: 11570810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd.
    Morlon A; Munnich A; Smahi A
    Hum Mol Genet; 2005 Dec; 14(23):3751-7. PubMed ID: 16251197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectodysplasin signaling in development.
    Mikkola ML; Thesleff I
    Cytokine Growth Factor Rev; 2003; 14(3-4):211-24. PubMed ID: 12787560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectodysplasin Signaling through XEDAR Is Required for Mammary Gland Morphogenesis.
    Wark AR; Aldea D; Tomizawa RR; Kokalari B; Warder B; Kamberov YG
    J Invest Dermatol; 2023 Aug; 143(8):1529-1537.e2. PubMed ID: 36804570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ectodysplasin and NFkappaB signalling pathways in odontogenesis.
    Courtney JM; Blackburn J; Sharpe PT
    Arch Oral Biol; 2005 Feb; 50(2):159-63. PubMed ID: 15721144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectodysplasin receptor-mediated signaling is essential for embryonic submandibular salivary gland development.
    Jaskoll T; Zhou YM; Trump G; Melnick M
    Anat Rec A Discov Mol Cell Evol Biol; 2003 Apr; 271(2):322-31. PubMed ID: 12629675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.
    Darnay BG; Ni J; Moore PA; Aggarwal BB
    J Biol Chem; 1999 Mar; 274(12):7724-31. PubMed ID: 10075662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of WEHI-231 cells from anti-IgM-induced growth arrest.
    Sutherland CL; Krebs DL; Gold MR
    J Immunol; 1999 Apr; 162(8):4720-30. PubMed ID: 10202013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repertoire of mouse ectodysplasin-A (EDA-A) isoforms.
    Hashimoto T; Cui CY; Schlessinger D
    Gene; 2006 Apr; 371(1):42-51. PubMed ID: 16423472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-kappaB activation induced by OX40 signaling.
    Takaori-Kondo A; Hori T; Fukunaga K; Morita R; Kawamata S; Uchiyama T
    Biochem Biophys Res Commun; 2000 Jun; 272(3):856-63. PubMed ID: 10860842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
    Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
    Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.